<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font17 { font-size : 17; } .font20 { font-size : 20; } .font22 { font-size : 22; } .font23 { font-size : 23; } .font27 { font-size : 27; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font31 { font-size : 31; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font31">vaccine </span>
   <span class="font27">virus </span>
   <span class="font27">WNV </span>
   <span class="font23">;:â€“. </span>
   <span class="font22">Nile </span>
   <span class="font20">West </span>
   <span class="font17">clinical </span>
   <span class="font16">antibodies </span>
   <span class="font16">{border-style </span>
   <span class="font15">human </span>
   <span class="font15">px;} </span>
   <span class="font15">#ffffff;} </span>
   <span class="font15">vaccines </span>
   <span class="font14">flavivirus </span>
   <span class="font14">using </span>
   <span class="font14">dengue </span>
   <span class="font13">DENV </span>
   <span class="font13">infection </span>
   <span class="font13">protection </span>
   <span class="font13">protective </span>
   <span class="font13">Dis. </span>
   <span class="font13">Infect </span>
   <span class="font13">candidates </span>
   <span class="font13">development </span>
   <span class="font13">efficacy </span>
   <span class="font13">ADE </span>
   <span class="font13">different </span>
   <span class="font12">ZIKV </span>
   <span class="font12">neutralizing </span>
   <span class="font12">studies </span>
   <span class="font12">virus. </span>
   <span class="font12">However, </span>
   <span class="font12">immune </span>
   <span class="font12">infections </span>
   <span class="font12">lead </span>
   <span class="font12">potential </span>
   <span class="font12">px; </span>
   <span class="font12">{font-family </span>
   <span class="font12">Vaccine. </span>
   <span class="font12">YFV </span>
   <span class="font12">animal </span>
   <span class="font12">case </span>
   <span class="font12">caused </span>
   <span class="font12">dose </span>
   <span class="font12">encephalitis </span>
   <span class="font12">endemic </span>
   <span class="font12">flaviviruses </span>
   <span class="font12">font-size </span>
   <span class="font12">inactivated </span>
   <span class="font12">individuals </span>
   <span class="font12">need </span>
   <span class="font12">severe </span>
   <span class="font11">Neutralizing </span>
   <span class="font11">addition, </span>
   <span class="font11">areas </span>
   <span class="font11">candidate </span>
   <span class="font11">cross-reactive </span>
   <span class="font11">demonstrated </span>
   <span class="font11">doses </span>
   <span class="font11">double; </span>
   <span class="font11">enhancement </span>
   <span class="font11">fever </span>
   <span class="font11">genetic </span>
   <span class="font11">immunity </span>
   <span class="font11">lineage </span>
   <span class="font11">mutations </span>
   <span class="font11">outbreaks </span>
   <span class="font11">phase </span>
   <span class="font11">safety </span>
   <span class="font11">;:. </span>
   <span class="font11">DNA </span>
   <span class="font11">Immunol. </span>
   <span class="font11">Rev </span>
   <span class="font11">Virol. </span>
   <span class="font11">Zika </span>
   <span class="font11">aged </span>
   <span class="font11">attenuated </span>
   <span class="font11">border-color </span>
   <span class="font11">border-width </span>
   <span class="font11">challenge </span>
   <span class="font11">chimeric </span>
   <span class="font11">conserved </span>
   <span class="font11">disease. </span>
   <span class="font11">doi:./j.vaccine.... </span>
   <span class="font11">domain </span>
   <span class="font11">emerging </span>
   <span class="font11">high </span>
   <span class="font11">highly </span>
   <span class="font11">humans </span>
   <span class="font11">led </span>
   <span class="font11">lethal </span>
   <span class="font11">licensure </span>
   <span class="font11">major </span>
   <span class="font11">older </span>
   <span class="font11">protect </span>
   <span class="font11">recombinant </span>
   <span class="font11">responses </span>
   <span class="font11">similar </span>
   <span class="font11">solid; </span>
   <span class="font11">specific </span>
   <span class="font11">strategies </span>
   <span class="font11">trials </span>
   <span class="font11">vaccination </span>
   <span class="font11">vaccines, </span>
   <span class="font11">{font-style </span>
   <span class="font11">{font-weight </span>
   <span class="font11">;:e. </span>
   <span class="font11">E-protein </span>
   <span class="font11">Emerg </span>
   <span class="font11">Europe, </span>
   <span class="font11">Expert </span>
   <span class="font11">Microbiol. </span>
   <span class="font11">RNA </span>
   <span class="font11">USA </span>
   <span class="font11">alternative </span>
   <span class="font11">approaches </span>
   <span class="font11">associated </span>
   <span class="font11">avoid </span>
   <span class="font11">binding </span>
   <span class="font11">bold </span>
   <span class="font11">cell </span>
   <span class="font11">correlate </span>
   <span class="font11">courier; </span>
   <span class="font11">data </span>
   <span class="font11">development. </span>
   <span class="font11">diagnosis </span>
   <span class="font11">doi:./... </span>
   <span class="font11">em; </span>
   <span class="font11">emergence </span>
   <span class="font11">expressing </span>
   <span class="font11">groups </span>
   <span class="font11">healthy </span>
   <span class="font11">heterologous </span>
   <span class="font11">humans, </span>
   <span class="font11">hydrogen </span>
   <span class="font11">immunization </span>
   <span class="font11">immunogenicity </span>
   <span class="font11">include </span>
   <span class="font11">including </span>
   <span class="font11">increase </span>
   <span class="font11">increased </span>
   <span class="font11">induce </span>
   <span class="font11">large </span>
   <span class="font11">licensed </span>
   <span class="font11">mice </span>
   <span class="font11">models </span>
   <span class="font11">occur </span>
   <span class="font11">provided </span>
   <span class="font11">pt;} </span>
   <span class="font11">review </span>
   <span class="font11">risk </span>
   <span class="font11">significant </span>
   <span class="font11">single </span>
   <span class="font11">spread </span>
   <span class="font11">strain </span>
   <span class="font11">study </span>
   <span class="font11">testing </span>
   <span class="font11">trial </span>
   <span class="font11">vaccine, </span>
   <span class="font11">vaccine. </span>
   <span class="font11">vaccines. </span>
   <span class="font11">van </span>
   <span class="font11">viral </span>
   <span class="font11">viruses </span>
   <span class="font11">zika </span>
  </p>
 </body>
</html>
